- $10.30bn
- $10.67bn
- $9.65bn
- 97
- 45
- 98
- 95
Annual balance sheet for Celestica, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 464 | 394 | 375 | 370 | 423 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,100 | 1,269 | 1,399 | 1,808 | 2,078 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,737 | 3,435 | 4,327 | 4,511 | 4,512 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 434 | 453 | 510 | 632 | 662 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,664 | 4,667 | 5,628 | 5,891 | 5,988 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,578 | 2,254 | 3,055 | 3,221 | 3,021 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,255 | 3,204 | 3,950 | 4,120 | 4,092 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 1,409 | 1,463 | 1,678 | 1,771 | 1,896 |
| Total Liabilities & Shareholders' Equity | 3,664 | 4,667 | 5,628 | 5,891 | 5,988 |
| Total Common Shares Outstanding |